Syno Capital: A global healthcare investment firm innovating solutions since 2015.
Location
New York City, NY, US
Founded
2015
Syno Capital is a global healthcare investment firm focused on developing breakthrough innovations to address healthcare challenges. Founded in 2015, the firm operates from New York and Hong Kong, targeting investments in companies that offer innovative solutions to complex medical problems. Syno Capital's investment strategy spans various stages, with a particular emphasis on Series A and B rounds.
The firm's portfolio includes notable companies such as Applied Therapeutics, Honor, LungLife AI, Orig3N, and PhaseBio Pharmaceuticals. Syno Capital's philosophy centers on driving progress through innovation, actively seeking to collaborate with visionary minds worldwide to tackle the most pressing healthcare issues. Their global presence allows them to identify and support promising healthcare startups across different markets.
Syno Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages